TriNetX Stock

trinetx.comHealthcareFounded: 1900Funding to Date: $94.31MM

TriNetX is the developer of a health research network designed to optimize clinical research and enable discoveries through the creation of real-world evidence.

Register for Details

For more details on financing and valuation for TriNetX, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Gadi Lachman
Chief Executive Officer & Board Member
David Fusari
Co-Chief Technology Officer & Vice President
Steve Kundrot
Co-Chief Technology Officer
Brian Flaherty
Chief Commercial Officer
Manfred Stapff Ph.D
Chief Medical Officer & Senior Vice President

Board Members

Bard Geesaman Ph.D
MPM Capital
Gadi Lachman
Jeff Margolis
Leslie Henshaw
Deerfield Management
Morana Jovan-Embiricos Ph.D
Tony Rosenberg
MPM Capital

Other companies like TriNetX in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$2.51B
Sector
Last Round Est. Valuation
$1.4B
Sector
Last Round Est. Valuation
$885.01MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$355.29MM
Sector
Last Round Est. Valuation
$8.18B
Sector
Last Round Est. Valuation
$1.61B
Sector
Last Round Est. Valuation
$263MM

News

/PRNewswire/ -- TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world...
The market for technology and services for clinical drug trials is expected to reach $68.9 billion over the next seven years. The trials, which are necessary to bring new healthcare treatments to market, are by necessity prolonged, complicated affairs. Several companies are vying for a piece of thi…